logo
Select company
Select metric
$ 6.15MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
38
Sector
76
Industry
90
History
100
$ 2.7Close
$ 1.41 - $ 4 52-Week Range
Ticker Information

Ticker

FBIO

Company Name

FORTRESS BIOTECH INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

FORTRESS BIOTECH INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

FBIO - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 6.35M$ -199K$ 6.15M
3/31/2025$ 7.27M$ -27.03M$ -19.76M
12/31/2024$ 7.31M$ -32.16M$ -24.85M
9/30/2024$ 7.41M$ -35.07M$ -27.66M
6/30/2024$ 7.68M$ -30.85M$ -23.17M
3/31/2024$ 8.43M$ -40.38M$ -31.95M
12/31/2023$ 8.07M$ -44.8M$ -36.73M
9/30/2023$ 7.73M$ -59.72M$ -51.98M
6/30/2023$ 7.36M$ -76.46M$ -69.11M
3/31/2023$ 5.26M$ -76.31M$ -71.05M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • FORTRESS BIOTECH INC's latest trailing twelve months (TTM) EBITDA stands at $ -36.67M.
  • Over the past 5 years, FORTRESS BIOTECH INC's average EBITDA has been $ -38.93M.
  • The median EBITDA for FORTRESS BIOTECH INC during this period was $ -34.31M
  • FORTRESS BIOTECH INC reached its highest EBITDA over the past 5 years at $ 6.15M.
  • The lowest EBITDA recorded by FORTRESS BIOTECH INC in the same timeframe $ -71.05M

FORTRESS BIOTECH INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
DOMH : DOMINARI HOLDINGS INC $ -18.5MICCC : IMMUCELL CORP $ 4.47MMGX : METAGENOMI INC $ -79.73MEQ : EQUILLIUM INC $ -19.7MADAP : ADAPTIMMUNE THERAPEUTICS PLC $ -149.75MBRNS : BARINTHUS BIOTHERAPEUTICS PLC $ -60.1MMRSN : MERSANA THERAPEUTICS INC $ -65.59MVRCA : VERRICA PHARMACEUTICALS INC $ -38.54MIVVD : INVIVYD INC $ -106.81MIRD : OPUS GENETICS INC $ -58.24M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for FORTRESS BIOTECH INC is calculated as follows: EBIT [ $ -40.48M ] + DepAmor [ $ 3.81M ]
(=) EBITDA [ $ -36.67M ]

FBIO - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -71.05M

Minimum

Mar 31, 2023

$ 6.15M

Maximum

Jun 30, 2025

$ -38.93M

Average

$ -34.31M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M